News

Published on 2 May 2024 on Insider Monkey via Yahoo Finance

Exelixis, Inc. (NASDAQ:EXEL) Q1 2024 Earnings Call Transcript


Article preview image

Exelixis, Inc. (NASDAQ:EXEL) Q1 2024 Earnings Call Transcript April 30, 2024

Exelixis, Inc. misses on earnings expectations. Reported EPS is $0.17 EPS, expectations were $0.28. EXEL isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Good day, ladies and gentlemen, and welcome to Exelixis First Quarter 2024 Financial Results Conference Call. My name is Towanda and I will be your operator today. As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to your host for today Mr. Varant Shirvanian, Director of Investor Relations. Please proceed.

NASDAQ.EXEL price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
3 TSX Penny Stocks With Market Caps Over CA$30M

Over the last 7 days, the Canadian market has remained flat, but it is up 22% over the past year ...

Simply Wall St. · via Yahoo Finance 21 Nov 2024

Should iShares MSCI USA Small-Cap Min Vol Factor ETF (SMMV) Be on Your Investing...

The ETF has added roughly 21.68% so far this year and...about 294 holdings, it effectively...

Zacks · via Yahoo Finance 21 Nov 2024

Zacks.com featured highlights Amazon, Maplebear, Exelixis and Doximity

In this regard, we ran a screener that yielded stocks Amazon.com, Maplebear Inc., Exelixis and...

Zacks · via Yahoo Finance 20 Nov 2024

Exelixis, Inc. (EXEL): Among Hedge Funds’ Top Biotech Stock Picks

We recently compiled a list of the 10 Largest Biotech Hedge Funds and Their Top Stock Picks. In t...

Insider Monkey · via Yahoo Finance 24 Sep 2024

Exelixis, Inc. (NASDAQ:EXEL) Q1 2024 Earnings Call Transcript

Exelixis, Inc. (NASDAQ:EXEL) Q1 2024 Earnings Call Transcript April 30, 2024 Exelixis, Inc. misse...

Insider Monkey via Yahoo Finance 2 May 2024

Exelixis (EXEL) Q1 Earnings Miss, Cabometyx Sales Fall Short

Exelixis, Inc. EXEL reported lower-than-expected results for the first quarter. Its shares fell 7...

Zacks via Yahoo Finance 1 May 2024

Exelixis Inc (EXEL) Q1 2024 Earnings: Mixed Results Amidst Restructuring Efforts

Total Revenue: Reported at $425.2 million for Q1 2024, showing an increase from $408.8 million in...

GuruFocus.com via Yahoo Finance 30 Apr 2024

Collegium (COLL) to Report Q1 Earnings: Here's What to Expect

Investors are expected to focus on top and bottom-line growth when Collegium Pharmaceutical COLL ...

Zacks via Yahoo Finance 29 Apr 2024

What's in the Cards for Amgen (AMGN) This Earnings Season?

Amgen AMGN will report first-quarter 2024 results on May 2, before market open. In the last repor...

Zacks via Yahoo Finance 29 Apr 2024

Institutional investors in Exelixis, Inc. (NASDAQ:EXEL) lost 3.8% last week but have reaped the...

Key Insights Significantly high institutional ownership implies Exelixis' stock price is sensitiv...

Simply Wall St. via Yahoo Finance 17 Apr 2024